Cargando…

Prognostic value of (18)F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer

This study evaluated the prognostic value of positron emission tomography/computed tomography (PET/CT) using (18)F‐fluoroazomycin arabinoside (FAZA) in patients with advanced non‐small‐cell lung cancer (NSCLC) compared with (18)F‐fluorodeoxyglucose (FDG). Thirty‐eight patients with advanced NSCLC (s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saga, Tsuneo, Inubushi, Masayuki, Koizumi, Mitsuru, Yoshikawa, Kyosan, Zhang, Ming‐Rong, Tanimoto, Katsuyuki, Horiike, Atsushi, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714693/ https://www.ncbi.nlm.nih.gov/pubmed/26292100 http://dx.doi.org/10.1111/cas.12771

Ejemplares similares

Imaging of Hypoxic Tumor: Correlation between Diffusion-weighted MR Imaging and (18)F-fluoroazomycin Arabinoside Positron Emission Tomography in Head and Neck Carcinoma
por: Imaizumi, Akiko, et al.
Publicado: (2019)

Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck
por: Toubaru, Sachiko, et al.
Publicado: (2013)

Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02)
por: Tanaka, Hisashi, et al.
Publicado: (2022)

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
por: Kawashima, Yosuke, et al.
Publicado: (2019)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
por: Yanagitani, Noriko, et al.
Publicado: (2020)

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma
por: Okuma, Yusuke, et al.
Publicado: (2020)

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01)
por: Uematsu, Shinya, et al.
Publicado: (2022)

A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979)

Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1
por: Miyauchi, Eisaku, et al.
Publicado: (2015)

Enhancement of the Cytotoxicity of Cytosine Arabinoside by Interleukin‐3
por: Tanaka, Masao
Publicado: (1992)

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients
por: Kitazono, Satoru, et al.
Publicado: (2019)

Single-photon emission computed tomography of spontaneous liver metastasis from orthotopically implanted human colon cancer cell line stably expressing human sodium/iodide symporter reporter gene
por: Inubushi, Masayuki, et al.
Publicado: (2012)

Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions
por: Takeuchi, Yasuto, et al.
Publicado: (2014)

High-dose cytosine arabinoside (Ara-C) in colorectal cancer.
por: Kanojia, M., et al.
Publicado: (1983)

Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983)

Extensin arabinoside chain length is modulated in elongating cotton fibre
por: Guo, Xiaoyuan, et al.
Publicado: (2019)

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
por: Nishio, M, et al.
Publicado: (2005)

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer
por: Horiike, A, et al.
Publicado: (2011)

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors
por: Tozuka, Takehiro, et al.
Publicado: (2020)

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
por: Yoshida, Chisato, et al.
Publicado: (2013)

(64)Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017)

Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen
por: Hatayama, Naoyuki, et al.
Publicado: (2016)

Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance
por: Okada, Koutaroh, et al.
Publicado: (2019)

FDG–PET findings associated with various medical procedures and treatments
por: Okuyama, Chio, et al.
Publicado: (2022)

Evaluation of Efficacy of Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models
por: Sugyo, Aya, et al.
Publicado: (2015)

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2018)

Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma
por: Saito, Yuichi, et al.
Publicado: (2016)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
por: Rohatiner, A. Z., et al.
Publicado: (1990)

Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
por: Sung, K. W., et al.
Publicado: (1997)

Effect of cytosine arabinoside on cerebellar neurofilaments during development: A sexual dimorphism
por: Koros, Christos, et al.
Publicado: (2014)

Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside
por: Neale, M H, et al.
Publicado: (1999)

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Green Technique-Solvent Free Microwave Synthesis and Antimicrobial Evaluation of New Thiopyridine Arabinosides
por: Maghrabi, Ibrahim A., et al.
Publicado: (2016)

Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis
por: Günther, Christian, et al.
Publicado: (2020)

The Anti-Senescence Activity of Cytokinin Arabinosides in Wheat and Arabidopsis Is Negatively Correlated with Ethylene Production
por: Kučerová, Zuzana, et al.
Publicado: (2020)

An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
por: Saga, Tsuneo, et al.
Publicado: (1990)

Evaluation of (89)Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2013)

Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_cp0jjdcm7p2hiu5br1mijh8fbr